Webinar - From Data to decisions: The convergence of AI, RWE & PSP data in market access
By Innomar Strategies
As stakeholders look for new ways to support access and reimbursement decisions in Canada, organizations are increasingly connecting patient support, real-world data, and advanced analytics. PSPs are evolving into important sources of longitudinal real-world data, while AI is helping teams analyze and apply evidence at scale. Together, these capabilities can support more informed access decisions.
Viewers will learn how to:
- Design patient support programs with data strategy in mind from day one
- Embed AI earlier in access planning and analysis
- Connect RWE, HEOR, and PSP insights to support payer and HTA evidence needs
- Align stakeholders around evidence standards and cross-functional collaboration
- Build transparency and governance into evidence strategies
This session is designed for pharmaceutical leaders across market access, medical affairs, evidence generation, patient support, and commercial teams who are looking to maximize data into a more integrated evidence strategy.
Speakers
Jessica Lovett
Alison Oliver
Belinda Yap
Fill out the form to watch the webinar



